Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jul;44(1):15–23. doi: 10.1038/bjc.1981.142

Initiation and promotion at different ages and doses in 2200 mice. II. Decrease in promotion by TPA with ageing.

F Stenbäck, R Peto, P Shubik
PMCID: PMC2010654  PMID: 6789854

Abstract

Using the data described in Paper I, we compare the effects of the same treatment timings and doses given at different ages. Initiation with DMBA at 68 weeks of age, followed 3 weeks later by TPA, has a significantly (P less than 0.0001) less rapid effect on subsequent tumour incidence than does initiation at 8 or at 48 weeks of age, followed 3 weeks later by TPA. We suggested that this is chiefly due not to changes in the numbers of cells initiated by DMBA, but rather to a decrease in the promotional efficacy of TPA in ageing mice.

Full text

PDF
15

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Klein-Szanto A. J., Major S. K., Slaga T. J. Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency. Carcinogenesis. 1980 May;1(5):399–406. doi: 10.1093/carcin/1.5.399. [DOI] [PubMed] [Google Scholar]
  2. Pereira M. A., Burns F. J., Albert R. E. Dose response for benzo(a)pyrene adducts in mouse epidermal DNA. Cancer Res. 1979 Jul;39(7 Pt 1):2556–2559. [PubMed] [Google Scholar]
  3. Peto R., Roe F. J., Lee P. N., Levy L., Clack J. Cancer and ageing in mice and men. Br J Cancer. 1975 Oct;32(4):411–426. doi: 10.1038/bjc.1975.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Stenbäck F., Peto R., Shubik P. Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells. Br J Cancer. 1981 Jul;44(1):1–14. doi: 10.1038/bjc.1981.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Van Duuren B. L., Smith A. C., Melchionne S. M. Effect of aging in two-stage carcinogenesis on mouse skin with phorbol myristate acetate as promoting agent. Cancer Res. 1978 Mar;38(3):865–866. [PubMed] [Google Scholar]
  6. Verma A. K., Rice H. M., Shapas B. G., Boutwell R. K. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Res. 1978 Mar;38(3):793–801. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES